by on 
PREVENTION OF T1DM, INDUCED BY ORAL ADMINISTRATION OF TRIPLE-DRUG COMBINATION OF DPP-4 INHIBITOR, PPI, AND GABA IN NOD MICE. A PROOF-OF-CONCEPT.
Prof. Shmuel Levit reports the results of his last study.
ATTD congress, Barselona, 2022.
_
Shmuel Levit, M.D. Ph.D. Head of Institute of Endocrinology, Diabetes & Metabolism, Assuta Medical Center, Tel Aviv, Israel; Professor of Kazan National Research Technological University. Russian Federation. Mob.: +972 50-451-5044
